Search results for "Cholera Toxin"

showing 5 items of 25 documents

Echovirus 1 Endocytosis into Caveosomes Requires Lipid Rafts, Dynamin II, and Signaling EventsV⃞

2004

Binding of echovirus 1 (EV1, a nonenveloped RNA virus) to the α2β1 integrin on the cell surface is followed by endocytic internalization of the virus together with the receptor. Here, video-enhanced live microscopy revealed the rapid uptake of fluorescently labeled EV1 into mobile, intracellular structures, positive for green fluorescent protein-tagged caveolin-1. Partial colocalization of EV1 with SV40 (SV40) and cholera toxin, known to traffic via caveosomes, demonstrated that the vesicles were caveosomes. The initiation of EV1 infection was dependent on dynamin II, cholesterol, and protein phosphorylation events. Brefeldin A, a drug that prevents SV40 transport, blocked the EV1 infection…

SucroseTime FactorsvirusesEndocytic cycleDynamin IIchemistry.chemical_compoundDynamin IIPhosphorylationInternalizationCytoskeletonIn Situ HybridizationIn Situ Hybridization Fluorescencemedia_commonGenes Dominant0303 health sciencesMicroscopy Videobiology030302 biochemistry & molecular biologyArticlesBrefeldin AEndocytosisCell biologyEnterovirus B HumanCholesterolRNA ViralElectrophoresis Polyacrylamide GelProtein BindingSignal TransductionCholera Toxinmedia_common.quotation_subjectIntegrinGreen Fluorescent ProteinsImmunoblottingEndocytosisTransfectionCell Line03 medical and health sciencesCapsidMembrane MicrodomainsViral entryCentrifugation Density GradientAnimalsMolecular Biology030304 developmental biologyBinding SitesBrefeldin ACell MembraneCell BiologyKineticschemistryViral replicationMicroscopy Fluorescencebiology.protein
researchProduct

Effects of adjuvants of the cholera toxin family on CD4 + T cell responses in a murine model of intrarectal immunization with rotavirus-like particles

2011

Mucosal immunization is an important goal of vaccine development to protect against pathogens that use mucosa as portals of entry. However, the use of non-replicating antigens requires the addition of adjuvants.Cholera-like enterotoxins, cholera toxin (CT) from Vibrio cholerae and the heat-labile enterotoxin (LT) from toxinogenic strains of E. coli, as well as the mutant LR-192G and their B subunits (CTB and LTB) have been shown to increase immune responses against unrelated co-administered antigens by mucosal routes. However, their mechanism of action is very complex and not completely understood and differences exist between holotoxins and B subunits and within molecules, differences exis…

[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyIL-2Cholera toxinLT-R192GVaccination muqueuseMucosal immunizationCD4 T lymphocyteE. coli heat-labile enterotoxinB subunitFoxp3[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyLymphocyte T CD4Lymphocyte T régulateurSous-unité BEntérotoxine thermolabile d’E. coliRegulatory T cell[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciencesAdjuvantToxine du choléra
researchProduct

The selective advantage of cystic fibrosis heterozygotes tested by aDNA analysis: A preliminary investigation

2000

Recently a heterozygote advantage was suggested to explain the high incidence (1:25 carrier individuals in Europeans) of the cystic fibrosis gene. This selective advantage was speculated to be due to a high resistance to chloride-secreting diarrhea, including cholera. Up to now the major efforts to test directly this hypothesis have been limited to animal models.

aDNAPathologymedicine.medical_specialtyCystic fibrosis genecystic fibrosis aDNA ancient DNAmedicine.disease_causeCystic fibrosisNOcystic fibrosis03 medical and health sciencesSelective advantagemedicineancient DNA030304 developmental biology0303 health sciencesbiology030305 genetics & heredityCholera toxinHeterozygote advantagemedicine.diseaseCholeraCystic fibrosis transmembrane conductance regulator3. Good healthDiarrheaAnthropologyImmunologybiology.proteinmedicine.symptom
researchProduct

Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and prot…

2006

ABSTRACTRotavirus (RV) is the main etiological agent of severe gastroenteritis in infants, and vaccination seems the most effective way to control the disease. Recombinant rotavirus-like particles composed of the viral protein 6 (VP6) and VP2 (2/6-VLPs) have been reported to induce protective immunity in mice when administered by the intranasal (i.n.) route. In this study, we show that administration of 2/6-VLPs by the intrarectal (i.r.) route together with either cholera toxin (CT) or a CpG-containing oligodeoxynucleotide as the adjuvant protects adult mice against RV infection. Moreover, when CT is used, RV shedding in animals immunized by the i.r. route is even reduced in comparison with…

medicine.medical_treatmentMESH : Cytokinesanimal diseasesMESH : Oligodeoxyribonucleotidesmedicine.disease_causeAntibodies ViralImmunoglobulin GMiceIntestinal mucosaMESH: RectumRotavirusMESH : FemaleMESH: AnimalsViralIntestinal MucosaInbred BALB C0303 health sciencesMice Inbred BALB CMESH: CytokinesMESH : Cholera ToxinMESH : Immunoglobulin A SecretoryMESH: Rotavirus Infections3. Good healthMESH : Rotavirus VaccinesVaccinationmedicine.anatomical_structureOligodeoxyribonucleotides[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH : RectumMESH: Intestinal MucosaCytokinesMESH: VirionMESH: ImmunizationFemaleAdjuvantMESH : Antibodies ViralCholera ToxinImmunologyMESH: Mice Inbred BALB CSpleenchemical and pharmacologic phenomenaBiologyMicrobiologyMESH : Intestinal Mucosa[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH: Rotavirus VaccinesRotavirus InfectionsAntibodies03 medical and health sciencesImmune systemVirologyVaccines and Antiviral AgentsMESH : MicemedicineMESH : Rotavirus InfectionsMESH : VirionAnimalsMESH: MiceMESH : Mice Inbred BALB CMESH: Cholera Toxin030304 developmental biology030306 microbiologyRotavirus VaccinesRectumVirionMESH : Immunizationbiochemical phenomena metabolism and nutritionSecretoryVirologyImmunoglobulin AMESH: Immunoglobulin A SecretoryImmunizationInsect ScienceImmunologyImmunoglobulin A Secretorybiology.proteinMESH: OligodeoxyribonucleotidesbacteriaImmunizationMESH : AnimalsMESH: FemaleMESH: Antibodies Viral
researchProduct

Genetic relationship between clinical and environmental Vibrio cholerae isolates in Tanzania: A comparison using repetitive extragenic palindromic (R…

2015

The bacterium causing cholera, Vibrio cholerae, is a marine organism and coastal waters are important reservoirs of the organism. There are more than 200 serogroups of V. cholerae, of which serogroups O1 and O139 are known to be the causative agent of the cholera. The main virulent factor in V. cholerae is cholera toxin gene (ctx) that is found from the epidemic O1 and O139 strains, but may also be found in some strains other than O1 and O139 (non-O1 and non-O139). In this study, 48 V. cholerae strains isolated from three estuaries of Tanzania and 20 stool isolates were characterized in terms of their serogroups and possession of ctx gene and then compared using two PCR based fingerprinting…

ta1172VirulencePlant Sciencemedicine.disease_causeMicrobiologyMicrobiologyIntergenic regionestuaries of TanzaniamedicineGeneticsbiologyenterobacterial repetitive intergenic consensus (ERIC)-PCRGenetic heterogeneityCholera toxinta1183Outbreakta3142vibrio choleraebiology.organism_classificationmedicine.diseasebacterial infections and mycosesCholeraInfectious Diseasesrepetitive extragenic palindromic (REP)-PCRVibrio choleraeBacteria
researchProduct